The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
Abstract
Key Points: High-dose intensive factor VIII treatment increases the risk for inhibitor development in patients with severe hemophilia A. In patients with severe hemophilia A, factor VIII prophylaxis decreases inhibitor risk, especially in patients with low-risk F8 mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Constructing Inverse Probability Weights for Marginal Structural Models
Cole, S. R., & Hernan, M. A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn164 · Cited by 2,796
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Manco-Johnson, M. J., Abshire, T. C., Shapiro, A. D., Riske, B., Hacker, M. R., Kilcoyne, R., Ingram, J. D., Manco-Johnson, M. L., Funk, S., Jacobson, L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067659 · Cited by 1,950 · cited 3×
“exposure days at intention to start prophylaxis 5 (2-12) 0-74”
BackgroundD'Agostino, R. B., Lee, M., Belanger, A. J., Cupples, L. A., Anderson, K., & Kannel, W. B. (1990) · Statistics in Medicine · doi:10.1002/sim.4780091214 · Cited by 798
White, G. C., Rosendaal, F. R., Aledort, L. M., Lusher, J. M., Rothschild, C., & Ingerslev, J. (2001) · PubMed · Cited by 798
Rosendaal, F., Aledort, L., Lusher, J., Rothschild, C., Ingerslev, J., & White, G. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615621 · Cited by 786
The epidemiology of inhibitors in haemophilia A: a systematic review
Wight, J., & Paisley, S. (2003) · Haemophilia · doi:10.1046/j.1365-2516.2003.00780.x · Cited by 627
Gouw, S. C., van der Bom, J. G., & Marijke van den Berg, H. (2007) · Blood · doi:10.1182/blood-2006-11-056291 · Cited by 495
Self-citationGouw, S. C., van den Berg, H. M., Oldenburg, J., Astermark, J., de Groot, P. G., Margaglione, M., Thompson, A. R., van Heerde, W., Boekhorst, J., Miller, C. H., et al. (2012) · Blood · doi:10.1182/blood-2011-09-379453 · Cited by 358
Self-citation
Cited by
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
Peyvandi, F., Mannucci, P. M., Garagiola, I., El-Beshlawy, A., Elalfy, M., Ramanan, V., Eshghi, P., Hanagavadi, S., Varadarajan, R., Karimi, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516437 · Cited by 494
Self-citationTargeting of Antithrombin in Hemophilia A or B with RNAi Therapy
Pasi, K. J., Rangarajan, S., Georgiev, P., Mant, T., Creagh, M. D., Lissitchkov, T., Bevan, D., Austin, S., Hay, C. R., Hegemann, I., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616569 · Cited by 367
Metadata
- Authors
- Gouw, S. C., van den Berg, H. M., Fischer, K., Auerswald, G., Carcao, M., Chalmers, E., Chambost, H., Kurnik, K., Liesner, R., Petrini, P., Platokouki, H., Altisent, C., Oldenburg, J., Nolan, B., Garrido, R. P., Mancuso, M. E., Rafowicz, A., Williams, M., Clausen, N., Middelburg, R. A., Ljung, R., & van der Bom, J. G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-05-16
- Volume
- 121
- Issue
- 20
- Pages
- 4046-4055
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2039215350
- Cited by
- 332
- References
- 31
- FWCI
- 20.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study. https://app.cochat.ai/papers/10.1182/blood-2012-09-457036
- The paper
- Gouw, S. C., van den Berg, H. M., Fischer, K., Auerswald, G., Carcao, M., Chalmers, E., Chambost, H., Kurnik, K., Liesner, R., Petrini, P., Platokouki, H., Altisent, C., Oldenburg, J., Nolan, B., Garrido, R. P., Mancuso, M. E., Rafowicz, A., Williams, M., Clausen, N., . . . van der Bom, J. G. (2013). Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study. Blood. https://doi.org/10.1182/blood-2012-09-457036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
